FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3041543875> ?p ?o ?g. }

• W3041543875 abstract "Medical ozone is used to treat various diseases, including numerous pathologies associated with chronic pain. Chronic pain may be treated by systemic administration of ozone, with ozonated autohemotherapy (OAH) being the commonly used method. In the clinic, intravenous infusion of ozonized saline has been used to treat various diseases. Compared with OAH, ozonized saline infusion is less technically demanding and causes minimal damage to veins. However, it has been indicated that ozone may oxidize saline and generate toxic substances, and therefore, the safety of ozone treatment has been questioned. In the present study, the potential chemical compounds produced from ozone and saline, including chlorite, chlorate and perchlorate, were examined at various time-points with ion chromatography-mass spectrometry (IC-MS). A control group (pure oxygen group) and an ozone group were included in the present study. Two subgroups were included within each group: A saline bottle (made from polypropylene) subgroup and an ozone-resistant blood transfusion bag [made from medical polyvinyl chloride, di(2-ethyl) hexyl phthalate plasticized] subgroup. For the ozone group, 100 ml saline and 100 ml medical ozone at various concentrations (20, 40 or 60 µg/ml in pure oxygen) were injected into the saline bottle or blood bag, and for the control group, 100 ml of pure oxygen was injected into the saline bottle or blood bag. The presence and the content of chlorite, chlorate and perchlorate were determined at different time-points (3, 6 and 15 days after mixing) by IC-MS. Chlorate was detected in the ozone groups at three time-points and its content increased as the ozone concentration and the reaction time increased. Under the same conditions (the same ozone concentration and the same incubation time), the chlorate content (0.90±0.14-7.69±0.48 µg/l) in the blood bag subgroup was significantly lower than that in the saline bottle subgroup (45.23±6.14-207.6±15.63 µg/l). However, chlorite and perchlorate were not detected at any time-point in the two groups. In addition, in the control group (pure oxygen group), chlorite, chlorate and perchlorate were not detected at any time-point. These results indicate that ozone reacts with saline to produce chlorate. Ozone may also react with the polypropylene saline bottle to increase the chlorate content in the bottled solution. Due to a lack of toxicology studies of chlorate in blood, it remains elusive whether ozonated saline and chlorate at the range of 0.90±0.14-7.69±0.48 µg/l has any toxic effects. The potential toxicity of chlorate should be considered when ozonated saline is used for clinical infusions." @default.
• W3041543875 created "2020-07-16" @default.
• W3041543875 creator A5004641049 @default.
• W3041543875 creator A5022117210 @default.
• W3041543875 creator A5028219372 @default.
• W3041543875 creator A5042186997 @default.
• W3041543875 creator A5060002817 @default.
• W3041543875 creator A5061628223 @default.
• W3041543875 creator A5077155749 @default.
• W3041543875 creator A5082920133 @default.
• W3041543875 date "2020-07-13" @default.
• W3041543875 modified "2023-10-09" @default.
• W3041543875 title "Detection of chlorite, chlorate and perchlorate in ozonated saline" @default.
• W3041543875 cites W1144326612 @default.
• W3041543875 cites W132473554 @default.
• W3041543875 cites W1505230665 @default.
• W3041543875 cites W1553601302 @default.
• W3041543875 cites W1579013097 @default.
• W3041543875 cites W2023553786 @default.
• W3041543875 cites W2028016850 @default.
• W3041543875 cites W2034047673 @default.
• W3041543875 cites W2045079631 @default.
• W3041543875 cites W2076542130 @default.
• W3041543875 cites W2103852741 @default.
• W3041543875 cites W2137202963 @default.
• W3041543875 cites W2162914271 @default.
• W3041543875 cites W2169449233 @default.
• W3041543875 cites W2256587461 @default.
• W3041543875 cites W2320665075 @default.
• W3041543875 cites W2414901604 @default.
• W3041543875 cites W2530993799 @default.
• W3041543875 cites W2540107078 @default.
• W3041543875 cites W2587357867 @default.
• W3041543875 cites W2594644448 @default.
• W3041543875 cites W2623776185 @default.
• W3041543875 cites W2737745629 @default.
• W3041543875 cites W2783380174 @default.
• W3041543875 cites W2795032098 @default.
• W3041543875 cites W2802391246 @default.
• W3041543875 cites W2808329362 @default.
• W3041543875 cites W2809706697 @default.
• W3041543875 cites W2809748799 @default.
• W3041543875 cites W2848465904 @default.
• W3041543875 cites W2888454249 @default.
• W3041543875 cites W2888762276 @default.
• W3041543875 cites W2895722060 @default.
• W3041543875 cites W2898203399 @default.
• W3041543875 cites W2902498556 @default.
• W3041543875 cites W2904448396 @default.
• W3041543875 cites W2913693747 @default.
• W3041543875 cites W2943877804 @default.
• W3041543875 cites W2975595453 @default.
• W3041543875 cites W2980789807 @default.
• W3041543875 cites W2982305057 @default.
• W3041543875 cites W2982421582 @default.
• W3041543875 cites W2990001394 @default.
• W3041543875 cites W4292004755 @default.
• W3041543875 cites W77159882 @default.
• W3041543875 doi "https://doi.org/10.3892/etm.2020.9005" @default.
• W3041543875 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7401830" @default.
• W3041543875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32765750" @default.
• W3041543875 hasPublicationYear "2020" @default.
• W3041543875 type Work @default.
• W3041543875 sameAs 3041543875 @default.
• W3041543875 citedByCount "2" @default.
• W3041543875 countsByYear W30415438752021 @default.
• W3041543875 countsByYear W30415438752023 @default.
• W3041543875 crossrefType "journal-article" @default.
• W3041543875 hasAuthorship W3041543875A5004641049 @default.
• W3041543875 hasAuthorship W3041543875A5022117210 @default.
• W3041543875 hasAuthorship W3041543875A5028219372 @default.
• W3041543875 hasAuthorship W3041543875A5042186997 @default.
• W3041543875 hasAuthorship W3041543875A5060002817 @default.
• W3041543875 hasAuthorship W3041543875A5061628223 @default.
• W3041543875 hasAuthorship W3041543875A5077155749 @default.
• W3041543875 hasAuthorship W3041543875A5082920133 @default.
• W3041543875 hasBestOaLocation W30415438751 @default.
• W3041543875 hasConcept C145148216 @default.
• W3041543875 hasConcept C159985019 @default.
• W3041543875 hasConcept C178790620 @default.
• W3041543875 hasConcept C179104552 @default.
• W3041543875 hasConcept C185592680 @default.
• W3041543875 hasConcept C192562407 @default.
• W3041543875 hasConcept C2777397205 @default.
• W3041543875 hasConcept C2777844515 @default.
• W3041543875 hasConcept C2779870107 @default.
• W3041543875 hasConcept C2780399513 @default.
• W3041543875 hasConcept C2780709120 @default.
• W3041543875 hasConcept C32236832 @default.
• W3041543875 hasConcept C42219234 @default.
• W3041543875 hasConcept C43617362 @default.
• W3041543875 hasConcept C508106653 @default.
• W3041543875 hasConcept C71924100 @default.
• W3041543875 hasConceptScore W3041543875C145148216 @default.
• W3041543875 hasConceptScore W3041543875C159985019 @default.
• W3041543875 hasConceptScore W3041543875C178790620 @default.
• W3041543875 hasConceptScore W3041543875C179104552 @default.
• W3041543875 hasConceptScore W3041543875C185592680 @default.
• W3041543875 hasConceptScore W3041543875C192562407 @default.
• W3041543875 hasConceptScore W3041543875C2777397205 @default.

• next